Gao Z, Gao Y, Wang Q, Wang Q, Lu P, Lv H
BMC Nephrol. 2025; 26(1):125.
PMID: 40050784
PMC: 11887227.
DOI: 10.1186/s12882-025-04045-y.
Liu J, Zhao J, He J, Li Y, Xu J, Xiao C
Apoptosis. 2025; .
PMID: 39987410
DOI: 10.1007/s10495-025-02079-z.
Padalko V, Posnik F, Adamczyk M
Int J Mol Sci. 2024; 25(18).
PMID: 39337438
PMC: 11431987.
DOI: 10.3390/ijms25189950.
Bond P, Verdegaal T, Smit D
Endocr Connect. 2024; 13(10).
PMID: 39212549
PMC: 11466264.
DOI: 10.1530/EC-24-0283.
Ting K
Front Cell Infect Microbiol. 2024; 14:1403915.
PMID: 39119289
PMC: 11306205.
DOI: 10.3389/fcimb.2024.1403915.
Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.
Song J, Xu S, Chen Q, Gou Y, Zhao C, Jia C
J Cell Mol Med. 2024; 28(14):e18543.
PMID: 39054575
PMC: 11272608.
DOI: 10.1111/jcmm.18543.
Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction.
Matsuoka T, Abe M, Kobayashi H
Int J Mol Sci. 2024; 25(7).
PMID: 38612557
PMC: 11012052.
DOI: 10.3390/ijms25073745.
Idiopathic erythrocytosis: a germline disease?.
Elli E, Mauri M, DAliberti D, Crespiatico I, Fontana D, Redaelli S
Clin Exp Med. 2024; 24(1):11.
PMID: 38244120
PMC: 10799805.
DOI: 10.1007/s10238-023-01283-y.
Activation of Intestinal HIF2α Ameliorates Iron-Refractory Anemia.
Yu Y, Su Y, Yang S, Liu Y, Lin Z, Das N
Adv Sci (Weinh). 2024; 11(12):e2307022.
PMID: 38243847
PMC: 10966566.
DOI: 10.1002/advs.202307022.
The hepatokine FGL1 regulates hepcidin and iron metabolism during anemia in mice by antagonizing BMP signaling.
Sardo U, Perrier P, Cormier K, Sotin M, Personnaz J, Medjbeur T
Blood. 2024; 143(13):1282-1292.
PMID: 38232308
PMC: 11103088.
DOI: 10.1182/blood.2023022724.
TGF-β-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer.
Wu J, Liao Q, Zhang L, Wu S, Liu Z
Oncol Res. 2024; 32(2):373-391.
PMID: 38186569
PMC: 10765122.
DOI: 10.32604/or.2023.031404.
Targeting ferroptosis and ferritinophagy: new targets for cardiovascular diseases.
Luan Y, Yang Y, Luan Y, Liu H, Xing H, Pei J
J Zhejiang Univ Sci B. 2024; 25(1):1-22.
PMID: 38163663
PMC: 10758208.
DOI: 10.1631/jzus.B2300097.
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges.
Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig H
Nat Rev Drug Discov. 2023; 23(3):175-200.
PMID: 38123660
DOI: 10.1038/s41573-023-00848-6.
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.
Zhao Y, Xiong W, Li C, Zhao R, Lu H, Song S
Signal Transduct Target Ther. 2023; 8(1):431.
PMID: 37981648
PMC: 10658171.
DOI: 10.1038/s41392-023-01652-9.
Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension.
Hopkins C, Wessel C, Chen O, El-Kersh K, Cave M, Cai L
Int J Biol Sci. 2023; 19(16):5036-5054.
PMID: 37928257
PMC: 10620830.
DOI: 10.7150/ijbs.85590.
Hypoxia and HIF-1α promote lytic KSHV infection.
Lee S, Naik N, Tombacz D, Gulyas G, Kakuk B, Boldogkoi Z
J Virol. 2023; 97(11):e0097223.
PMID: 37909728
PMC: 10688315.
DOI: 10.1128/jvi.00972-23.
Hypoxia-inducible factor upregulation by roxadustat attenuates drug reward by altering brain iron homoeostasis.
Yan P, Li N, Ma M, Liu Z, Yang H, Li J
Signal Transduct Target Ther. 2023; 8(1):355.
PMID: 37718358
PMC: 10505610.
DOI: 10.1038/s41392-023-01578-2.
Myeloid Hif2α is not essential to maintain systemic iron homeostasis.
Jain C, Parimi S, Huang W, Hannifin S, Singhal R, Das N
Exp Hematol. 2023; 125-126:25-36.e1.
PMID: 37562670
PMC: 11046397.
DOI: 10.1016/j.exphem.2023.08.001.
The effects of intracellular iron availability on the outcome of infection in mice.
Mostafa E, Ahmed F, Yahia S, Ibrahim A, Elbahaie E
J Parasit Dis. 2023; 47(3):608-618.
PMID: 37520204
PMC: 10382456.
DOI: 10.1007/s12639-023-01603-9.
LRG1 Associates with Iron Deficiency Anemia Markers in Adolescents.
Alhammad R, Abu-Farha M, Rahman A, Thanaraj T, Shaban L, Alsabah R
Nutrients. 2023; 15(14).
PMID: 37513518
PMC: 10384480.
DOI: 10.3390/nu15143100.